Navigation Links
Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
Date:6/24/2011

SAN DIEGO, June 24, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced results from a retrospective analysis of more than 778,000 patients that showed the addition of BYETTA® (exenatide) injection to pre-existing diabetes treatment regimens was associated with a reduced likelihood of heart failure, especially among patients receiving insulin. These findings will be presented in a poster session at the 71st Scientific Sessions of the American Diabetes Association in San Diego on June 25 from 11:30 a.m. to 1:30 p.m. PDT.

The retrospective analysis used data from the GE Healthcare Centricity electronic medical record to analyze the likelihood of heart failure for BYETTA in combination with certain other diabetes treatments compared with control groups of patients not treated with BYETTA. Across all therapies, patients who received BYETTA were 54 percent less likely to experience heart failure compared to patients not treated with BYETTA.

"Compared with the general population, people with diabetes have an increased risk of heart disease, with at least double the risk of developing heart failure. That's why it is imperative that we understand the role diabetes treatments may play in patients' cardiovascular health," said Christian Weyer, M.D., senior vice president, research and development, Amylin Pharmaceuticals. "In addition to retrospective analyses like this one, our EXSCEL cardiovascular outcomes study is underway to thoroughly and prospectively evaluate cardiovascular effects of exenatide."

EXSCEL (EXenatide Study of Cardiovascular Event Lowering) is designed to determine if there are favorable cardiovascular effects of exenatide treatment, using BYDUREON™ (exenatide extended-relea
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Ill. , May 20, 2013 Landauer, ... in personal and environmental radiation measurement and monitoring, outsourced ... announced today that its Board of Directors declared, at ... cash dividend of $0.55 per share for the third ... on July 3, 2013, to shareholders of record on ...
(Date:5/20/2013)... May 20, 2013  Valeant Pharmaceuticals International, Inc. (NYSE: ... senior management team will make a presentation at the 34 ... 11, 2013 at 9:20 a.m. PT. The conference will be ... CA. A live webcast and audio ... Web site at www.valeant.com . Click on Investor Relations, ...
(Date:5/20/2013)... VIEW, Calif. , May 20, 2013 /PRNewswire-iReach/ ... results of the first study demonstrating detection of ... Yersinia pestis and Bacillus anthracis ... Control and Prevention,s list of potential bio-threats. This ... Science and Technology Laboratory, Salisbury ...
Breaking Medicine Technology:Landauer, Inc. Declares Regular Cash Dividend 2Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2
... April 18, 2011 Altitude Organic Corporation (Pinksheets: ... announced today that it has launched its third-party ... headquarters.  Visit the DoctorMMJ.com website ( www.DoctorMMJ.com ) ... and entirely legal medical marijuana evaluation in Arizona. ...
... 2011 Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ... Administration (FDA) has accepted for review the Company,s Biologics ... of the neovascular form of age-related macular degeneration (wet ... priority review of its BLA.  A Priority Review designation ...
Cached Medicine Technology:Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 2Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 3FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 2FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 3
(Date:5/21/2013)... 21, 2013 The birth control safety ... who have used the contraceptive NuvaRing. A new report ... clot injuries has increased in recent months*. , DrugRisk ... and devices with the latest safety alerts, recalls, studies ... are experiencing similar side effects and decide if they ...
(Date:5/20/2013)... 2013 USA Book News announced Monday ... Peak Performance" won the top honor in its 2013 ... over a multitude of international titles published from 2011-2013, ... acclaim from both mainstream and new age audiences looking ... and spiritually. , “The Infinity Zone” is ...
(Date:5/20/2013)... Texas (PRWEB) May 21, 2013 ... on product type into two categories - semi-automated ... market is classified into five categories, namely, hospitals, ... market is forecast till 2017. Automated external defibrillators ... of sudden cardiac arrest victims. Considering the life-saving ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Recent ... importance of using green and sustainable inputs in ... has implemented regulations to promote the use of ... Packaging and Labelling Services industry . “Tax subsidies ... trend,” says IBISWorld industry analyst Deonta Smith. “For ...
(Date:5/20/2013)... Florida (PRWEB) May 20, 2013 In order ... supplemental health and wellness team from DrSmartphoneMD launched an article ... serious sunburns. , The series launched with the ... that members of the DrSmartphoneMD program are not one of ... team explained that more than 90% of all skin cancer ...
Breaking Medicine News(10 mins):Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Combat Skin Cancer In Summer Months 2
... study shows that combining high resolution and high sensitivity ... emission computed tomography (SPECT) scans, said researchers at SNM,s ... rays so that only those traveling parallel to a ... it is not yet possible to focus radiation with ...
... skin patch can safely and successfully treat basal cell ... cancers, according to researchers at the SNM,s 56th Annual ... is nontoxic and could be an excellent alternative to ... treatments is difficult. "While basal cell carcinoma is ...
... pandemic level, a new article http://www.cmaj.ca/cgi/rapidpdf/cmaj.090866 in ... oseltamivir (Tamiflu) and zanamivir (Relenza) are relatively safe drugs ... women, especially those in the third trimester, are at ... influenza virus. The study was conducted by researchers ...
... , Brand unveils four-month awareness campaign featuring Len Dawson, Ken Griffey ... with ZERO - The Project to End Prostate Cancer , ... staggering one in six men and 192,000 men expected to be ... KMB ) and the Depend brand today announced a ...
... Insight built on SAP(R) BusinessObjects(TM) software , ... /PRNewswire/ -- Tata Consultancy Services (TCS) ... business solutions and outsourcing firm, has launched Provider ... on SAP(R) BusinessObjects(TM) software for hospitals and other ...
... stories and demands for solutions to lawmakers in Washington , ... , ATLANTA, June 15 As lawmakers wrangle over health reform ... one mom is making sure people,s voices are heard. Kathie McClure, ... states to expose the gaps in our tattered healthcare system safety ...
Cached Medicine News:Health News:New skin cancer patch: Possible alternative to surgery 2Health News:Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer' 2Health News:Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer' 3Health News:Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer' 4Health News:Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 2Health News:Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 3Health News:Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 4Health News:Mom on Mission for Quality, Affordable Healthcare for All Drives Purple Bus Across Nation Gathering Stories 2Health News:Mom on Mission for Quality, Affordable Healthcare for All Drives Purple Bus Across Nation Gathering Stories 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: